Microdose Psychedelic Insights is a cutting-edge conference production company focused around promoting content, financial analysis and engaging events designed to drive the psychedelics industry into the forefront of modern medicine. In partnership with Pharmala Biotech Inc and ACS Pharmacology & Translational Science, Microdose Psychedelic Insights will host the upcoming MDMA Conference: A Molecular Masterclass in an entirely virtual format on June 15, 2021. The event will present a scientific deep dive into the dynamic field of MDMA therapeutics, exploring the potential of MDMA at the intersection of drug development and safety, clinical care and applications, law and regulation, business and markets, science and research, as well as history and culture. This year’s event will feature a series of discussion panels and six keynote presentations, including an address by Rick Doblin, Ph.D., the executive director of the Multidisciplinary Association for Psychedelic Studies (“MAPS”).
To view the full press release, visit https://ibn.fm/X3OKK
About Microdose Psychedelics Insights
Microdose Psychedelic Insights is your guide to the psychedelic medicine industry. With a vision to shift the world’s perception of psychedelic medicine, it distributes and creates the most compelling content, financial analysis, engaging events, and groundbreaking education to drive the psychedelics industry to the forefront of modern medicine. For more information, visit www.Microdose.buzz.
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
